REFERENCES
1.Babayigit A, Olmez D, Uzuner N, Cakmakci H, Tuncel T, Karaman O.2009.
A neglected problem of developing countries: Non-cystic fibrosis
bronchiectasis. Ann Thorac Med. 4:21–24.
2.Chang AB.2011. Bronchiectasis: so much yet to learn and to do.
Paediatr Respir Rev. 12:89–90.
3. Kapur N, Karadag B.2011.Differences and similarities in non-cystic
fibrosis bronchiectasis between developing and affluent countries,
Paediatr Respir Rev.12(2); 91–6.
4.Eastham KM, Fall AJ ,Mitchell L,Spencer D A.2004.The need to redefine
non cystic fibrosis bronchiectasis in childhood .Thorax .59:324-327.
5. Anuradha KWDA, Gunathilaka PKG, Wickramasinghe VP. 2019.Non-cystic
fibrosis bronchiectasis in children: Aetiology, clinical profile and
outcome in a single unit. Sri Lanka J of Child Health.48(2):111–6.
6.Randell
SH, Boucher RC.2006.Effective Mucus Clearance Is Essential for
Respiratory Health,
AM
J Resp Cell Mol. 35(1): 20–8.
7. Kliegman RM, Stanton BMD, St. Gerne J, Schor NF, editors, Nelson
Textbook of Paediatrics, 20th edition. Philadelphia:
Elsevier; 2016
8. Schafer J,GrieseM,Chandrasekaran R,2018. Pathogenesis, Imaging and
clinical characteristics of CF and non-CF bronchiectasis.BMC Pulm Med.79
9.Ning W,Ming QJ,Jin-Fu.2011.Brobchiectasis management in China,What we
can learn from European Respiratory Society Guidelines.Chin Med
J.131(16):1891-1893
10.Chang AB, Bush A,Grimwood K.2018.Bronchiectasis in Children:diagnosis
and treatment.The lancet .392(10150):866-879.
11.Poeta M,Maglione M,Borrelli M,Santamaria F. 2020. Non-cyatic fibrosis
bronchiectasis in children and adolescents: Neglected and emerging
issues. Paediatr
Neonatol.61(3):255-262.http://doi.org/10.1016/j.pedneo.2019.09.013
12. Gupta AK,Lodha R,Kabra SK. 2015.Non Cystic Fibrosis
Bronchiectasis.Indian J Paediatr.82:938-944.
13.Nathan AM,de Bruyne J A,Peng K,Thavagnanam S.2017.Review:Quality of
life in children with non-CF bronchiectasis.Front Paediatr.April.
14. Snijders D, Dominguez FB,Calgaro
S, Bertozzi I, Escribano A
M, Perilongo
G, Barbato
A.2015.Mucociliary clearance techniques for treating non cystic fibrosis
bronchiectasis: Is there evidence? Int J Immunopathol
Pharmacol.28(2):150-159
.
15.Mark R, Elkins P. 2012.Mechanisms and applications of hypertonic
saline.J Roy Soc Med. 20:40-43
16.Gupta S, Ahmed F, Lodha R,Gupta YK, Kabra SK. 2012.Comparison of
Effects of 3% and 7% Hypertonic Saline Nebulization on Lung Function
in Children with CysticFibrosis: A Double-Blind Randomized, Controlled
Trial. J Trop Pediatr. 58( 5)
17.Eng PA, Morton J,DouglassJA, Riedler J, Wilson J, Robertson
CF.1996.Short term efficacy of ultrasonically nebulized hypertonic
saline in cystic fibrosis. Pediatr Pulmonol. 21 :77-83
18.Pasteur MG,Bilton D, Hill AT.2010. British thoracic society
guidelines for non –CF bronchiectasis. Thorax.65(Suppl.1): il-i58
19.Chang AB, Bell SC,Paul JT et al. 2015. Chronic Suppurative lung
disease and bronchiectasis in children and adults inAustralia and New
zealandThoracic Society of Australia and New Zealand guidelines.Med J
Aust. 202 (1): 21-23.
20.Polverino E, Goeminne PC,McDonnell MJ et al .2017. European
respiratory society guidelines for the management of non cystic fibrosis
bronchiectasis. Ann Thorac Med.12:135-161
21.Kellett F. Redfern J,Niven R. 2005. Evolution of nebulized hypertonic
saline (7%) as an adjunct to physiotherapy in patients with
bronchiectasis .Respir Med.99:27-31
22. Kellett F. Robert NM. 2011.Nebulized 7% hypertonic saline improves
lung function and quality of life in bronchiectasis .Respir
Med.105:1831-1835
23.American thoracic society guidelines on lung functions-Spirometry
2017 update www.thoracic.org
24.Chang AB.2011.Bronchiectasis: so much yet to learn and to do.
Paediatr Respir Rev.12:89–90.
25. Maiz Carro L, Martienz-Garcia MA.2019. Nebulized hypertonic saline
in noncystic fibrosis bronchiectasis: a comprehensive review. Ther Adv
Respir Dis.13.
26.Nicolson CH, stirlingRG,Borg BM, Button BM. The long term effects of
inhaled hypertonic saline 6% in non-CF bronchiectasis .Respir Med
2012;106:661-667.
27.Nicolson CHH, Stirling RG, Brog BM, Button BM, Wilson JW,Holand
AE,2012.The long term effect of inhaled hypertonic saline 6% in
non-cystic fibrosis bronchiectasis. Respir Med. 106;661-667.
28.Kumar
A,
Lodha
R,
Kumar
P,
Kabra
SK.2015.Non-cystic fibrosis bronchiectasis in children: clinical
profile, aetiology and outcome. Indian Paediatr.52(1):35-7.
29.Murray M.P,Pentland J.L, HilA.Tl,2009.A randomised crossover trial of
chest physiotherapy in non cystic fibrosis bronchiectasis. Eur Respir
J.34: 1086–1092
30.Tarrant BJ,Maitre CLE, Romero L,Steward R,Button BR,Thompson
BR,Holland AE.2017. Mucoactive agents for chronic, non-cystic fibrosis
lung disease:A systematic review and meta-analysis.
Respirology.22:1084–1092 .